Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - NovoCure Ltd | nvcr-20191231xex322.htm |
| EX-32.1 - EX-32.1 - NovoCure Ltd | nvcr-20191231xex321.htm |
| EX-31.2 - EX-31.2 - NovoCure Ltd | nvcr-20191231xexx312.htm |
| EX-31.1 - EX-31.1 - NovoCure Ltd | nvcr-20191231xex311.htm |
| EX-21 - EX-21 - NovoCure Ltd | nvcr-2019x1231xex21.htm |
| EX-4.1 - EX-4.1 - NovoCure Ltd | exhibit41sharedescript.htm |
| 10-K - 10-K - NovoCure Ltd | nvcr-20191231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form S-8 (File Nos. 333-209854, 333-217619, 333-224606 and 333-232896) pertaining to the NovoCure Limited Employee Share Purchase Plan, the NovoCure Limited 2015 Omnibus Incentive Plan, the NovoCure Limited 2013 Share Option Plan and the Standen Limited 2003 Share Option Plan of our report dated February 27, 2020, with respect to the consolidated financial statements of NovoCure Limited, and the effectiveness of internal control over financial reporting of NovoCure Limited, included in this Annual Report (Form 10-K) for the year ended December 31, 2019.
/s/ Kost Forer Gabbay and Kasierer | ||||||||
| Tel Aviv, Israel | KOST FORER GABBAY AND KASIERER | |||||||
| February 27, 2020 | A member of EY Global | |||||||